Science
Will a diabetes drug demonstrate cardiovascular benefits by November 30, 2026?
Ends 30 November 2026 · 75 days left · ₦58.9M volume
⚠️ Warning: Insider trading is not permitted. Do not trade on non-public information.
YES contract price
₦617₦ this month
₦58.9M volume
3,456 traders · 75 days left
Order book — YES
Sell orders (asks)
- ₦663,702
- ₦658,226
- ₦643,945
- ₦633,759
- ₦628,606
Buy orders (bids)
- ₦602,812
- ₦596,316
- ₦589,811
- ₦577,431
- ₦568,795
About this market
Medical Science: Diabetes treatment advancement. Phase 3 trials evaluating cardio-protective effects.
Resolution rules
Resolves YES if trial shows significant cardiovascular benefit, or NO if neutral/negative.
Place an order
- Price per contract
- ₦61
- Exchange fee (2%)
- ₦100
- Contracts
- 80.32
- Potential payout
- ₦8,032
- Profit if yes wins
- +₦3,032
Demo trading with virtual naira. Contracts settle at ₦100 if correct, ₦0 if not. Not financial advice — 18+ only.
Exact Score
Predict the exact final score. Click a cell to select, then buy a contract.
₦58.9M traded·3,456 traders
0
1
2
3
4
5
6
7
8
9
10
0
1
2
3
4
5
6
7
8
9
10
Home (left/rows) vs Away (top/columns)